TY  - CHAP
M1  - Book, Section
TI  - Chapter 197. Human T-Lymphotropic Viruses
A1  - Tschachler, Erwin
A2  - Goldsmith, Lowell A.
A2  - Katz, Stephen I.
A2  - Gilchrest, Barbara A.
A2  - Paller, Amy S.
A2  - Leffell, David J.
A2  - Wolff, Klaus
Y1  - 2012
N1  - 
T2  - Fitzpatrick's Dermatology in General Medicine, 8e
AB  - |PrintHuman  T-Lymphotropic  Virus  1-Induced  Skin  Diseases  at  a  GlanceAn  estimated  10–20  million  people  are  infected  by  human  T-cell  lymphotropic  virus  type  1  (HTLV-1)  worldwide,  with  endemic  pockets  of  high  prevalence  in  Southern  Japan  and  the  Caribbean  islands.Infective  dermatitis  is  a  recalcitrant  form  of  eczema  occurring  in  HTLV-1-infected  children  in  the  Caribbean.Adult  T-cell  leukemia  (ATL)  shows  monoclonal  HTLV-1  provirus  integration  in  tumor  cells  and  occurs  in  four  clinical  variants,  all  of  which  tend  to  show  skin  involvement:Smoldering  ATL—5%  of  all  cases.Chronic  ATL—15%  of  all  cases.Lymphoma-type  ATL—20%  of  all  cases.Acute  ATL—60%  of  all  cases.The  prognosis  of  lymphoma-type  and  acute  ATL  is  very  poor  despite  chemotherapy,  with  a  projected  4-year  survival  of  5%.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=56089694
ER  -